BURGER, Michal, Karel HEJDUK, Karel NĚMEČEK, Karolína KREUTEROVÁ, Kateřina FRÖHLICH, Petra OVESNÁ, Tomáš PAVLÍK and Jiří JARKOVSKÝ. Analytický report databáze VILP: přípravek JEVTANA (kabazitaxel) (Analytical report of the VILP database: druh JEVTANA (kabazitaxel)). Brno: Masarykova univerzita, 2014, 25 pp.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Analytický report databáze VILP: přípravek JEVTANA (kabazitaxel)
Name (in English) Analytical report of the VILP database: druh JEVTANA (kabazitaxel)
Authors BURGER, Michal (203 Czech Republic, belonging to the institution), Karel HEJDUK (203 Czech Republic, guarantor, belonging to the institution), Karel NĚMEČEK (203 Czech Republic), Karolína KREUTEROVÁ (203 Czech Republic), Kateřina FRÖHLICH (203 Czech Republic, belonging to the institution), Petra OVESNÁ (203 Czech Republic, belonging to the institution), Tomáš PAVLÍK (203 Czech Republic, belonging to the institution) and Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution).
Edition Brno, 25 pp. 2014.
Publisher Masarykova univerzita
Other information
Original language Czech
Type of outcome Research report
Field of Study 30200 3.2 Clinical medicine
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14710/14:00080270
Organization unit Institute of Biostatistics and Analyses
Keywords in English prostate cancer; kabazitaxel; treatment
Changed by Changed by: Mgr. Jakub Gregor, Ph.D., učo 16577. Changed: 22/6/2015 10:26.
Abstract
Tato zpráva sumarizuje data shromážděná z reálné klinické praxe při používání tzv. vysoce inovativního léčivého přípravku (VILP) JEVTANA (kabazitaxel) pro indikaci dospělých pacientů k léčbě v kombinaci s prednisonem nebo prednisolonem s metastazujícím karcinomem prostaty
Abstract (in English)
The report summarizes data from the real clinical practice on the use of the drug JEVTANA (kabazitaxel) for treatment of adult patients with metastatic prostate cancer in combination with prednisone or prednisolone.
PrintDisplayed: 27/7/2024 18:09